Rankings
▼
Calendar
VTYX Q2 2023 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
VTYX
Ventyx Biosciences, Inc.
$1B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$57M
Net Income
-$53M
EPS (Diluted)
$-0.91
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$49M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$349M
Total Liabilities
$21M
Stockholders' Equity
$328M
Cash & Equivalents
$52M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$57M
-$20M
-180.2%
Net Income
-$53M
-$20M
-166.0%
← FY 2023
All Quarters
Q3 2023 →